Author Question: Regena, age 50, is likely to have __________ than 25-year-old Owen. A) a smaller thymus B) ... (Read 62 times)

ishan

  • Hero Member
  • *****
  • Posts: 546
Regena, age 50, is likely to have __________ than 25-year-old Owen.
 
  A) a smaller thymus
  B) softer artery walls
  C) more fast-twitch muscle fibers
  D) thicker cartilage in the joints

Question 2

__________ secrete antibodies into the bloodstream that multiply, capture foreign substances, and permit the blood system to destroy them.
 
  A) T cells
  B) B cells
  C) Telomeres
  D) Antigens



Eunice618

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

Answer: A

Answer to Question 2

Answer: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library